TNF-α regulates epithelial expression of MMP-9 and integrin αvβ6 during tumour promotion. A role for TNF-α in keratinocyte migration?

Oncogene

Volumn 23, Issue 41, 2004, Pages 6954-6966

  Scott, Kate A ^a   Arnott, Caroline H ^a   Robinson, Stephen C ^a   Moore, Robert J ^a   Thompson, Richard G ^a   Marshall, John F ^a   Balkwill, Frances R ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Epidermis; Matrix metalloproteinase; Skin carcinogenesis; TPA; Wound healing

Indexed keywords

ALPHA5 INTEGRIN; ALPHAVBETA6 INTEGRIN; BETA6 INTEGRIN; CYTOKINE; GELATINASE B; MATRIX METALLOPROTEINASE; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; INTEGRIN; TISSUE INHIBITOR OF METALLOPROTEINASE 3; TUMOR ANTIGEN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDERMIS; GENE EXPRESSION; IN SITU HYBRIDIZATION; KERATINOCYTE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKIN CANCER; SKIN CARCINOGENESIS; WOUND HEALING; ANIMAL; CELL MOTION; CYTOLOGY; EPITHELIUM; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHYSIOLOGY; SKIN TUMOR;

ANIMALIA;

ANIMALS; ANTIGENS, NEOPLASM; CELL MOVEMENT; EPIDERMIS; EPITHELIUM; GENE EXPRESSION REGULATION, NEOPLASTIC; INTEGRINS; KERATINOCYTES; MATRIX METALLOPROTEINASE 9; MICE; RNA, MESSENGER; SKIN NEOPLASMS; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TUMOR NECROSIS FACTOR-ALPHA; WOUND HEALING;

EID: 4644262855     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1207915     Document Type: Article

References (44)

1. Arnott CH, Scott KA, Moore RJ, Hewer A, Phillips DH, Parker P, Balkwill FR and Owens DM. (2002). Oncogene, 21, 4728-4738.
2. Arnott CH, Scott KA, Moore RJ, Robinson SC, Thompson RG and Balkwill FR. (2004). Oncogene, 23, 1902-1910.
3. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z and Hanahan D. (2000). Nat. Cell Biol., 2, 737-744.
4. Binder RL, Gallagher PM, Johnson GR, Stockman SL, Smith BJ, Sundberg JP and Conti CJ. (1997). Mol. Carcinog., 20, 151-158.
5. Breuss JM, Gillett N, Lu L, Sheppard D and Pytela R. (1993). J. Histochem. Cytochem., 41, 1521-1527.
6. Breuss JM, Gallo J, DeLisser HM, Klimanskaya IV, Folkesson HG, Pittet JF, Nishimura SL, Aldape K, Landers DV and Carpenter W et al. (1995). J. Cell Sci., 108, 2241-2251.
7. Buck M, Houglum K and Chojkier M. (1996). Am. J. Pathol., 149, 195-204.
8. Chomczynski P and Sacchi N. (1987). Anal. Biochem., 162, 156-159.
9. Coussens LM, Tinkle CL, Hanahan D and Werb Z. (2000). Cell, 103, 481-490.
10. DiGiovanni J, Rho O, Xian W and Beltran L. (1994). Prog. Clin. Biol. Res., 387, 113-138.
11. Frame S, Crombie R, Liddell J, Stuart D, Linardopoulos S, Nagase H, Portella G, Brown K, Street A, Akhurst R and Balmain A. (1998). Philos. Trans. Roy. Soc. London B, 353, 839-845.
12. Han YP, Tuan TL, Hughes M, Wu HY and Garner WL. (2001). J. Biol. Chem., 276, 22341-22350.
13. Hanemaaijer R, Verheijen JH, Maguire TM, Visser H, Toet K, McDermott E, O'Higgins N and Duffy MJ. (2000). Int. J. Cancer, 86, 204-207.
14. Hubner G, Brauchle M, Smola H, Madlener M, Fassler R and Werner S. (1996). Cytokine, 8, 548-556.
15. Kobayashi T, Kishimoto J, Ge Y, Jin W, Hudson DL, Ouahes N, Ehama R, Shinkai H and Burgeson RE. (2001). EMBO Rep., 2, 604-608.
16. Leber TM and Balkwill FR. (1997). Anal. Biochem., 249, 24-28.
17. Lee RH, Efron DT, Tantry U, Stuelten C, Moldawer LL, Abouhamze A and Barbul A. (2000). Wound Repair Regen., 8, 547-553.
18. Liabakk NB, Talbot I, Smith RA, Wilkinson K and Balkwill F. (1996). Cancer Res., 56, 190-196.
19. Locksley RM, Killeen N and Lenardo MJ. (2001). Cell, 104, 487-501.
20. Lund LR, Romer J, Bugge TH, Nielsen BS, Frandsen TL, Degen JL, Stephens RW and Dano K. (1999). EMBO J., 18, 4645-4656.
21. MacEwan DJ. (2002). Cell Signal, 14, 477-492.
22. McCawley LJ, O'Brien P and Hudson LG. (1998). J. Cell Physiol., 176, 255-265.
23. Milner R and Campbell IL. (2003). J. Immunol., 170, 3850-3858.
24. Mohan R, Chintala SK, Jung JC, Villar WV, McCabe F, Russo LA, Lee Y, McCarthy BE, Wollenberg KR, Jester JV, Wang M, Welgus HG, Shipley JM, Senior RM and Fini ME. (2002). J. Biol. Chem., 277, 2065-2072.
25. Moore RJ, Owens DM, Stamp G, Arnott C, Burke F, East N, Holdsworth H, Turner L, Rollins B, Pasparakis M, Kollias G and Balkwill F. (1999). Nat. Med., 5, 828-831.
26. Mori R, Kondo T, Ohshima T, Ishida Y and Mukaida N. (2002). FASEB J., 16, 963-974.
27. Morris RJ. (2000a). J. Clin. Invest., 106, 3-8.
28. Morris RJ, Tryson KA and Wu KQ. (2000b). Cancer Res., 60, 226-229.
29. Murphy JE, Morales RE, Scott J and Kupper TS. (2003). J. Immunol., 170, 5697-5703.
30. Nakao S, Kuwano T, Ishibashi T, Kuwano M and Ono M. (2003). J. Immunol., 170, 5704-5711.
31. Naylor MS, Stamp GW, Davies BD and Balkwill FR. (1994). Int. J. Cancer, 58, 50-56.
32. Nielsen BS, Timshel S, Kjeldsen L, Sehested M, Pyke C, Borregaard N and Dano K. (1996). Int. J. Cancer, 65, 57-62.
33. Papathoma AS, Zoumpourlis V, Balmain A and Pintzas A. (2001). Mol. Carcinog., 31, 74-82.
34. Scott KA, Holdsworth H, Balkwill FR and Dias S. (2000). Br. J. Cancer, 83, 1538-1543.
35. Scott KA, Moore RJ, Arnott CH, East N, Thompson RG, Scallon BJ, Shealy DJ and Balkwill FR. (2003). Mol. Cancer Ther., 2, 445-451.
36. Steel JH, Jeffery RE, Longcroft JM, Rogers LA and Poulsom R. (1998). Eur. J. Histochem., 42, 143-150.
37. Suganuma M, Okabe S, Marino MW, Sakai A, Sueoka E and Fujiki H. (1999). Cancer Res., 59, 4516-4518.
38. Thomas GJ, Lewis MP, Hart IR, Marshall JF and Speight PM. (2001a). Int. J. Cancer, 92, 641-650.
39. Thomas GJ, Poomsawat S, Lewis MP, Hart IR, Speight PM and Marshall JF. (2001b). J. Invest. Dermatol., 116, 898-904.
40. Thomas GJ, Hart IR, Speight PM and Marshall JF. (2002). Br. J. Cancer, 87, 859-867.
41. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA and Opdenakker G. (2002). Crit. Rev. Biochem. Mol. Biol., 37, 375-536.
42. Watt FM. (2002). EMBO J., 21, 3919-3926.
43. Weeks BH, He W, Olson KL and Wang XJ. (2001). Cancer Res., 61, 7435-7443.
44. Yuspa SH. (1998). J. Dermatol. Sci., 17, 1-7.